MTOR and depressive symptom measurement: Here, we tested whether alterations in NMDA receptors and associated mTOR signaling in the PFC are part of the pathology of depression and are part of the therapeutic responses to antidepressant actions of ketamine and Yueju using a CMS mouse model.